Summary report of the Td-3 workshop: Characterization of 83 antibodies against prostate-specific antigen

Tumor Biology

Volumn 20, Issue SUPPL. 1, 1999, Pages 1-12

  Stenman, U H ^a   Paus, E ^b   Allard, W J ^c   Andersson, I ^d   Andres C ^e   Barnett, T R ^c   Backer, C ^f   Belenky, A ^c   Bellanger, L ^e   Pellegrino, C M ^c   Bormer O P ^b   Davis, G ^c   Dowell, B ^g   Grauer, L S ^h   Jette, D C ⁱ   Karlsson, B ^d   Kreutz, F T ⁱ   Van Der Kwast, T M ^j   Lauren, L ^g   Leinimaa, M ^a   Leinonen, J ^a   Lilja, H ^f   Linton, H J ^h   Nap, M ^k   Nilsson, O ^d   Ng, P C ^c   Nustad, K ^b   Peter, A ^d   Pettersson, K ^m   Piironen, T ^m   Rapp, J ^g   Rittenhouse, H G ^h   Rye, Phil D ^b   Seguin, P ^e   Slota, J ^g   Sokoloff, R L ^h   Suresh, M R ⁱ   Very, D L ^c   Wang, T J ^h   Wigheden, I ^f   Wolfert, R L ^h   Yeung, K K ^c   Zhang, W M ^a   Zhou, Z ^c   Hilgers, J ^l   more..

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c BAYER CORPORATION   (United States)

^d Fujirebio Diagnostics Inc   (Sweden)

^e CIS Bio International   (France)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g ABBOTT LABORATORIES   (United States)

^h Hybritech Incorporated   (United States)

ⁱ UNIVERSITY OF ALBERTA   (Canada)

^j ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^k Zuyderland Medical Centre   (Netherlands)

^l ACADEMIC MEDICAL CENTER   (Netherlands)

^m NONE

more..

Author keywords

Antibody; ISOBM; Prostate; PSA; Workshop

Indexed keywords

EPITOPE; KALLIKREIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 165; MONOCLONAL ANTIBODY 19D5; MONOCLONAL ANTIBODY 2E9; MONOCLONAL ANTIBODY 365; MONOCLONAL ANTIBODY 4G10; MONOCLONAL ANTIBODY 5A10; MONOCLONAL ANTIBODY 92 28464; MONOCLONAL ANTIBODY 9B10; MONOCLONAL ANTIBODY CED1F; MONOCLONAL ANTIBODY E74; MONOCLONAL ANTIBODY E86; MONOCLONAL ANTIBODY E87; MONOCLONAL ANTIBODY E88; MONOCLONAL ANTIBODY H50; MONOCLONAL ANTIBODY MM1; MONOCLONAL ANTIBODY PCS 3; MONOCLONAL ANTIBODY PCS2; MONOCLONAL ANTIBODY PS80; MONOCLONAL ANTIBODY PS98; MONOCLONAL ANTIBODY PSA30; MONOCLONAL ANTIBODY PSA4082 A1CI; MONOCLONAL ANTIBODY PSB999; MONOCLONAL ANTIBODY PSS233; MONOCLONAL ANTIBODY TD 11B3 4; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; CLASSIFICATION; CONFERENCE PAPER; CROSS REACTION; EPITOPE MAPPING; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNORADIOMETRIC ASSAY; IMMUNOREACTIVITY; MOLECULAR MODEL; NOMENCLATURE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0032726502     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056523     Document Type: Conference Paper

References (38)

1. Wang MC, Valenzuela LA, Murphy GP, Chu TM: Purification of a human prostate-specific antigen. Invest Urol 1979;17:159-163.
2. Lilja H: A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985;76:1899-1903.
3. Sensabaugh GF: Isolation and characterization of a semen-specific protein from human seminal plasma: A potential new marker for semen identification. J Forensic Sci 1978; 23:106-115.
4. Wang TJ, Rittenhouse HG, Wolfert RL, Lynne CM, Brackett NL: PSA concentrations in seminal plasma. Clin Chem 1998;44:895-896.
5. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317: 909-916.
6. Oesterling JE: Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-923.
7. Stenman U-H, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51:222-226.
8. Lilja H, Christensson A, Dahlen U, Matikainen MT, Nilsson O, Pettersson K, Lövgren T: Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem 1991;37: 1618-1625.
9. Pettersson K, Piironen T, Seppala M, Liukkonen L, Christensson A, Matikainen MT, Suonpaa M, Lövgren T, Lilja H: Free and complexed prostate-specific antigen (PSA): In vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex. Clin Chem 1995;41:1480-1488.
10. Christensson A, Laurell CB, Lilja H: Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 1990;194: 755-763.
11. Zhou AM, Tewari PC, Bluestein BI, Caldwell GW, Larsen FL: Multiple forms of prostate-specific antigen in serum: Differences in immunorecognition by monoclonal and polyclonal assays. Clin Chem 1993;39: 2483-2491.
12. Zhang W-M, Finne P, Leinonen J, Vesalainen S, Nordling S, Rannikko S, Stenman U-H: Characterization and immunological determination of the complex between prostate-specific antigen and α2-macroglobulin. Clin Chem 1998;44:2471-2479.
13. Zhang W-M, Leinonen J, Kalkkinen N, Dowell B, Stenman U-H: Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid. Clin Chem 1995;41:1567-1573.
14. Leinonen J, Zhang W-M, Paus E, Stenman U-H: Reactivity of 77 antibodies to prostate-specific antigen with isoenzymes and complexes of prostate-specific antigen. Tumor Biol 1999;20(suppl 1):28-34.
15. Mikolajczyk SD, Grauer LS, Millar LS, Hill TM, Kumar A, Rittenhouse HG, Wolfert RL, Saedi MS: A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serum. Urology 1997;50: 710-714.
16. Chapdelaine P, Paradis G, Tremblay RR, Dube JY: High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen. FEBS Lett 1988;236:205-208.
17. Henttu P, Lukkarinen O, Vihko P: Expression of the gene coding for human prostate-specific antigen and related hGK-1 in benign and malignant tumors of the human prostate. Int J Cancer 1990;45:654-660.
18. Lövgren J, Piironen T, Overmo C, Dowell B, Karp M, Pettersson K, Lilja H, Lundwall Å: Production of recombinant PSA and HK2 and analysis of their immunologic cross-reactivity. Biochem Biophys Res Commun 1995;213:888-895.
19. Piironen T, Lövgren T, Karp M, Eerola R, Pettersson K, Lilja H, Lundwall Å: Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum. Clin Chem 1996;42:1034-1041.
20. Jette DC, Kreutz FT, Malcolm BA, Wishart DS, Noujaim AA, Suresh MR: Epitope mapping of prostate-specific antigen with monoclonal antibodies. Clin Chem 1996;42: 1961-1969.
21. Corey E, Wegner SK, Corey MJ, Vessella RL: Prostate-specific antigen: Characterization of epitopes by synthetic peptide mapping and inhibition studies. Clin Chem 1997;43: 575-584.
22. Nilsson O, Peter A, Andersson I, Nilsson K, Grundstrom B, Karlsson B: Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA. Br J Cancer 1997;75:789-797.
23. Piironen T, Villoutreix BO, Becker C, Hollingsworth K, Vihinen M, Bridon D, Qiu X, Rapp J, Dowell B, Lövgren T, Pettersson K, Lilja H: Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling. Protein Sci 1998;7:259-269.
24. Villoutreix BO, Getzoff ED, Griffin JH: A structural model for the prostate disease marker, human prostate-specific antigen. Protein Sci 1994;3:2033-2044.
25. Paus E, Nustad K, Børmer OP: Epitope mapping and affinity estimation of 83 antibodies against prostate-specific antigen. Tumor Biol 1999;20(suppl 1):52-69.
26. Becker C, Wigheden I, Lilja H: Characterization of epitope structure tor 53 monoclonal antibodies against prostate-specific antigen. Tumor Biol 1999;20(suppl 1):13-17.
27. Nilsson O, Andersson I, Peter A, Karlsson PB: Characterization of antibodies to prostate-specific antigen. Tumor Biol 1999;20(suppl 1): 43-51.
28. Wang TJ, Linton HJ, Sokoloff RL, Grauer LS, Rittenhouse HG, Wolfert RL: Western blotting analysis of antibodies to prostate-specific antigen: Specificities for prostate-specific antigen and prostate-specific antigen fragments. Tumor Biol 1999;20(suppl 1):79-85.
29. Zhou Z, Barnett TR, Very DL Jr, Ng PC, Pellegrino CM, Davis G, Belenky A, Allard WJ, Yeung KK: Analysis of monoclonal antibodies to prostate-specific antigen: Reactivity with native and recombinant prostate-specific antigen. Tumor Biol 1999;20(suppl 1):86-93.
30. Villoutreix BO, Lilja H, Pettersson K, Lövgren T, Teleman O: Structural investigation of the alpha-1-antichymotrypsin:prostate-specific antigen complex by comparative model building. Protein Sci 1996;5:836-851.
31. Bellanger L, Andrès C, Seguin P: Epitope mapping of 53 antibodies against prostate-specific antigen. Tumor Biol 1999;20(suppl 1):18-23.
32. Allard WJ, Zhou Z, Yeung KK: Novel immunoassay for the measurement of complexed prostate-specific antigen in serum. Clin Chem 1998;44:1216-1223.
33. Wang TJ, Linton HJ, Rittenhouse HG, Wolfert RL: Western blotting analysis of antibodies to prostate-specific antigen: Cross-reactivity with human kallikrein-2. Tumor Biol 1999;20(suppl 1):75-78.
34. Slota J, Lauren L, Rapp J, Dowell B: Immunological grouping of 53 antibodies against prostate-specific antigen. Tumor Biol 1999;20(suppl 1): 70-74.
35. Leinonen J, Leinimaa M, Zhang W-M, Piironen T, Petterson K, Lilja H, Dowell B, Stenman U-H: Reactivity of anti-PSA monoclonal antibodies with recombinant human kallikrein-2. Tumor Biol 1999;20 (suppl 1):35-37.
36. Jette DC, Kreutz FT, Suresh MR: Relative affinity and specificity of monoclonal antibodies against prostate-specific antigen. Tumor Biol 1999;20(suppl 1):24-27.
37. Nap M, van der Kwast TM: Immunohistochemical characterization of 53 monoclonal antibodies to prostate-specific antigen. Tumor Biol 1999;20(suppl 1):38-42.
38. Lövgren J, Rajakoski K, Karp M, Lundwall A, Lilja H: Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein-2. Biochem Biophys Res Commun 1997;238:549-555.